The diagnosis of genetic metabolic disorders in neonates typically involves newborn screening, which is a standard practice in many countries. Screening tests are performed using a small blood sample taken from a heel prick. Advanced techniques such as tandem mass spectrometry (MS/MS) are used to detect multiple metabolic disorders simultaneously. If an abnormality is detected, confirmatory tests including genetic testing and biochemical assays are conducted to establish a definitive diagnosis.
